Literature DB >> 10215679

Interaction between medullary and spinal delta1 and delta2 opioid receptors in the production of antinociception in the rat.

R W Hurley1, T S Grabow, R J Tallarida, D L Hammond.   

Abstract

Previous work supports the existence of two types of delta opioid receptor (delta1 and delta2) and a role of both subtypes in the spinal cord and the ventromedial medulla (VMM) in the production of antinociception. Although it is well established that spinal and supraspinal mu opioid receptors interact in a synergistic manner to produce antinociception, little is known about the interaction of delta opioid receptors. This study used isobolographic analysis to determine how delta1 and delta2 opioid receptors in the VMM interact with their respective receptors in the spinal cord to produce antinociception. Concurrent administration of the delta1 opioid receptor agonist [D-Pen2,D-Pen5]enkephalin at spinal and supraspinal sites in a fixed-dose ratio produced antinociception in an additive manner in the tail-flick test. In contrast, concurrent administration of very low doses of the delta2 opioid receptor agonist [D-Ala2,Glu4]deltorphin at spinal and medullary sites produced antinociception in a synergistic manner. However, as the total dose of [D-Ala2,Glu4]deltorphin increased, this interaction converted to additivity. These observations suggest that different mechanisms mediate the antinociceptive effects of different doses of delta2 opioid receptor agonists. The difference in the nature of the interaction produced by delta1 and delta2 opioid receptor agonists provides additional evidence for the existence of different subtypes of the delta opioid receptor. These results also suggest that delta2 opioid receptor agonists capable of crossing the blood-brain barrier will be more potent or efficacious analgesics than delta1 opioid receptor agonists after systemic administration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10215679

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation.

Authors:  R W Hurley; D L Hammond
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

2.  Quantitative methods for assessing drug synergism.

Authors:  Ronald J Tallarida
Journal:  Genes Cancer       Date:  2011-11

3.  Activation of delta-opioid receptors reduces excitatory input to putative gustatory cells within the nucleus of the solitary tract.

Authors:  Mingyan Zhu; Young K Cho; Cheng-Shu Li
Journal:  J Neurophysiol       Date:  2008-11-19       Impact factor: 2.714

4.  Synaptic mechanism for functional synergism between delta- and mu-opioid receptors.

Authors:  Zhi Zhang; Zhizhong Z Pan
Journal:  J Neurosci       Date:  2010-03-31       Impact factor: 6.167

5.  Contribution of endogenous enkephalins to the enhanced analgesic effects of supraspinal mu opioid receptor agonists after inflammatory injury.

Authors:  R W Hurley; D L Hammond
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

6.  Removing TRPV1-expressing primary afferent neurons potentiates the spinal analgesic effect of delta-opioid agonists on mechano-nociception.

Authors:  Shao-Rui Chen; Hui-Lin Pan
Journal:  Neuropharmacology       Date:  2008-05-22       Impact factor: 5.250

7.  Behavioral consequences of delta-opioid receptor activation in the periaqueductal gray of morphine tolerant rats.

Authors:  Michael M Morgan; Michelle D Ashley; Susan L Ingram; MacDonald J Christie
Journal:  Neural Plast       Date:  2009-02-25       Impact factor: 3.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.